Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTX-011 as the Foundation of a Non-opioid, Multimodal Analgesic Regimen Following Hernia Repair
NCT03907176Phase 3Completed
- Sponsor
- Heron Therapeutics, Inc.
- Start
- Apr 2019
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine + meloxicam in postoperative pain, sponsored by Heron Therapeutics, Inc.. Started Apr 2019; status: completed.
02
Drugs
bupivacaine + meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03907176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03907176.